Loading...
Loading...
CST Brands
CST is expected to report its Q1 earnings at $0.19 per share on revenue of $3.07 billion.
Fossil Group
FOSL is projected to post its Q1 earnings at $1.17 per share on revenue of $771.60 million.
Take-Two Interactive Software
TTWO is expected to post its Q4 earnings at $0.10 per share on revenue of $202.51 million.
CTI Industries
CTIB is estimated to report its Q1 earnings at $0.02 per share on revenue of $15.75 million.
URS
URS is projected to post its Q1 earnings at $0.68 per share on revenue of $2.68 billion.
LATAM Airlines Group SA
LFL is expected to post its Q1 earnings at $0.20 per share on revenue of $3.42 billion.
Gladstone Investment
GAIN is projected to post its Q4 earnings at $0.17 per share on revenue of $8.90 million.
First Horizon National
FHN is expected to report its Q2 earnings at $0.17 per share on revenue of $286.98 million.
Synacor
SYNC is estimated to post a Q1 loss at $0.05 per share on revenue of $24.53 million.
Diana Containerships
DCIX is projected to report its Q1 earnings at $0.01 per share on revenue of $13.22 million.
Intrawest Resorts Holdings
SNOW is expected to post its Q3 earnings at $2.69 per share on revenue of $294.89 million.
Cosan
CZZ is estimated to post its Q1 earnings at $0.16 per share.
ViaSat
VSATLoading...
Loading...
is projected to post its Q4 earnings at $0.11 per share on revenue of $348.98 million.
Biodel
BIOD is expected to post a Q1 loss at $0.24 per share.
First Majestic Silver
AG is estimated to post its Q1 earnings at $0.10 per share on revenue of $63.35 million.
Dr. Reddy's Laboratories
RDY is expected to report its Q4 earnings at $0.52 per share.
YuMe
YUME is estimated to post a Q1 loss at $0.15 per share on revenue of $35.36 million.
Vertex Energy
VTNR is projected to report its Q1 earnings at $0.03 per share on revenue of $42.48 million.
Idera Pharmaceuticals
IDRA is estimated to report a Q1 loss at $0.08 per share on revenue of $3.00 thousand.
USA Technologies
USAT is projected to report its Q3 earnings at $0.00 per share on revenue of $10.63 million.
P&F Industries
PFIN is expected to report its quarterly results.
INSYS Therapeutics
INSY is projected to report its Q1 earnings at $0.28 per share on revenue of $45.63 million.
Loading...
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in